Yubo International Biotech Limited
YBGJOTCHealthcare● Active
$0.01
+$0.00(+0.00%)
Market Cap$1006454
P/E Ratio—
52W High$0.1776
52W Low$0.0079
Yubo International Biotech Limited（YBGJ）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · YBGJ · 截至 2026-06-15
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.01M | $0.01M | $0.02M | $0.03M | $1.38M |
| Net Receivables | $0.43M | $0.44M | $0.35M | $0.56M | $0.43M |
| Inventory | $0.02M | $0.04M | $0.32M | $0.16M | $0.07M |
| Total Current Assets | $0.67M | $0.68M | $0.75M | $1.06M | $1.91M |
| PP&E Net | $0.12M | $0.68M | $1.41M | $3.34M | $0.39M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.04M | $0.05M | $0.07M | $0.04M | $0.05M |
| Total Assets | $0.85M | $1.53M | $2.35M | $4.59M | $2.44M |
| Liabilities | |||||
| Short-Term Debt | $0.00M | $0.37M | $0.40M | $0.77M | $0.32M |
| Accounts Payable | $1.06M | $1.04M | $0.55M | $0.28M | $0.10M |
| Total Current Liabilities | $2.79M | $4.72M | $2.52M | $2.79M | $1.28M |
| Long-Term Debt | $0.00M | $0.00M | $0.39M | $1.93M | $0.00M |
| Total Liabilities | $2.79M | $4.83M | $2.91M | $4.72M | $1.28M |
| Stockholders Equity | |||||
| Retained Earnings | ($7.74M) | ($6.66M) | ($3.69M) | ($2.49M) | ($0.94M) |
| Total Stockholders Equity | ($1.95M) | ($3.42M) | ($0.57M) | ($0.13M) | $1.17M |
| Total Liab & Equity(computed) | $0.84M | $1.41M | $2.35M | $4.59M | $2.44M |
| Debt Summary | |||||
| Total Debt | $0.08M | $0.48M | $0.79M | $2.69M | $0.32M |
| Net Debt | $0.07M | $0.47M | $0.77M | $2.67M | ($1.07M) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-15 · USD · M
深入了解Yubo International Biotech Limited
关于Yubo International Biotech Limited（YBGJ）资产负债表
Yubo International Biotech Limited总资产$0.00B，现金及短期投资$0.00B，总负债$0.00B，总债务$0.00B，股东权益($0.00B)。
常见问题
YBGJ · 4 问Yubo International Biotech Limited总债务$0.00B，净债务$0.00B。
YBGJ total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15